Federal contractor · NEW HAVEN, CT

ALEXION PHARMACEUTICALS INC

ALEXION PHARMACEUTICALS INC received $733.6K in federal contract obligations in FY2026, on 3 awards (+40% vs FY2025). Since FY2017: $4.4M. Its largest customer was Department of Veterans Affairs ($733.6K).

Obligations · FY2026: $733.6K
New awards: 3
Sole-source: 0.0%
Single offer: 86%

UEI: DKCXLGANZAN3
Parent company: ASTRAZENECA UK LTD

Other than small business

Open in the contracts explorer Relationship graph

Company family

Grouped from reported parent companies (UEI) and, where marked, AI judgments that two records name the same organization or group.

Part of the ASTRAZENECA PHARMACEUTICALS LP company family: 3 registered entities, $734.1K in FY2026 together. See the family

ASTRAZENECA PHARMACEUTICALS LPWILMINGTON, DE · Family page
Reported parent$500
MEDIMMUNE LLCGAITHERSBURG, MD
Reported parent$0

Spending by fiscal year

Obligations per federal fiscal year (October–September).

952.3KFY2017
472.6KFY2018
177.5KFY2019
70.7KFY2022
1.4MFY2024
522.2KFY2025
733.6KFY2026

Top buying agencies

Obligations in FY2026.

Department of Veterans Affairs$733.6K100%
3 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Health & medical$733.6K100%

Where the work was performed

Denton County, TX$733.6K100%

Integrity signals

Shares of the year's obligations, next to the country's.

Low competition86%
US 39% · $629K
Sole-source awards0.0%
US 30% · $0
Single-offer competitions86%
US 8.7% · $629K
Urgency justifications0.0%
US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

STRENSIQ 80 MG/0.8 ML INJ.$1.3M
Department of Veterans Affairs· Denton County, TX· Health & medical· Oct 20, 2025 – Feb 24, 2026· 36C26026F0055
STRENSIQ$626.9K
Department of Veterans Affairs· Denton County, TX· Health & medical· Dec 20, 2024 – Apr 2, 2026· 36C26025F0093
STRENSIQ 80 MG$104.7K
Department of Veterans Affairs· Denton County, TX· Health & medical· Jul 21, 2026 – Jul 21, 2026· 36C24526N0739

Teaming partners

Companies this company reported paying, primes that reported paying it, from FFATA subaward reports.

Companies it pays

No subawards reported to other companies.

Primes that pay it

1 company · $112.2K reported

CHILDREN'S HOSPITAL CORPORATION, THE$112.2K
BOSTON, MA · 1 subaward

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 9, 2026, loaded Oct 9, 2026 · Subawards loaded from 2021.

Lobbying and PAC activity

Organizations in House lobbying disclosures and FEC records whose names an AI judgment matched to this company. Those records carry no identifier shared with contracts, so every match is by name.

Across the company family of ASTRAZENECA PHARMACEUTICALS LP (3 recipients).

Matched organizations

AstraZeneca Pharmaceuticals LPAI match · 100%
ALEXION PHARMACEUTICALS INC.AI match · 99%
ALEXION PHARMACEUTICALS INC. PACAI match · 99%

Lobbying · 2025: $5.1M; 29 reports
Lobbying · 2023–2026: $15.9M; $15.9M in its own reports
PAC giving · 2026: $450.5K; 2 PACs

Lobbying by year

2023$3.9M
22 reports
2024$2.9M
25 reports
2025$5.1M
29 reports
2026$4M
12 reports

Top issues

Health issues74 reports
Medicare and Medicaid61 reports
Pharmacy15 reports
Copyright, patent and trademark14 reports
Taxation and the Internal Revenue Code14 reports
Labor issues, antitrust and workplace6 reports
Miscellaneous tariff bills5 reports
Clean air and water4 reports

Who was contacted

U.S. HOUSE OF REPRESENTATIVES75 reports
U.S. SENATE69 reports
White House Office30 reports
Centers For Medicare and Medicaid Services (CMS)27 reports
Health & Human Services - Dept of (HHS)25 reports
Food & Drug Administration (FDA)8 reports
Labor - Dept of (DOL)6 reports
U.S. Trade Representative (USTR)6 reports
Commerce - Dept of (DOC)4 reports
Council on Environmental Quality (CEQ)4 reports

Houses of Congress and federal agencies the reports list as contacted (a report names every one for all its issues).

Lobbying firms hired

Todd Strategy Group$1.1M
15 reports
W Strategies, LLC$1.1M
14 reports
FEROX STRATEGIES$840K
14 reports
Forbes-Tate$700K
14 reports
PRIME POLICY GROUP$290K
6 reports
Manatt, Phelps, and Phillips$60K
5 reports
JEFFREY J. KIMBELL & ASSOCIATES, INC.$40K
6 reports

Registrants who are individuals are counted, not named.

PAC giving to candidates by party, 2026 cycle

Democratic$242K54%
Republican$208.5K46%

PACs sponsored

ZENECA INC. POLITICAL ACTION COMMITTEE (AZPAC)$901K raised this cycle
ALEXION PHARMACEUTICALS INC. PAC$130K raised this cycle

PACs these organizations sponsor (connected organizations in FEC records). A PAC gives employees' and members' voluntary contributions, not the company's own money.

Lobbying amounts are the filers' own good-faith estimates on quarterly LD-2 reports (the law asks for amounts rounded to $10,000; under $5,000 need not be itemized), latest amendment only. When an organization files its own report, it replaces what outside firms report for it that quarter. Matches are by name. Lobbying and political giving are legal and public: they show engagement with government, not influence over any award. Correlation is not influence: these organizations' lobbying and their contracts are shown side by side, and nothing here implies either affected the other.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 9, 2026, loaded Oct 9, 2026 · 2023–2026.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 9, 2026, loaded Oct 9, 2026 · 2026, 2024, 2022.

Matches: Analisa AI name judgments (entity-match@1), updated Oct 5, 2026.

Congress: members and bills

Through the organizations matched to this company: members of Congress whose campaigns received contributions from their PACs, and the bills their lobbying reports named. Shown beside the company's contracts as a comparison, not a cause.

Members whose campaigns received from its PACs, 2026 cycle

Katherine M. Clark$10K
D-MA-5 · House · 2 PACs
Donald G. Davis$10K
D-NC-1 · House · 2 PACs
Brett Guthrie$10K
R-KY-2 · House · 2 PACs
H. Morgan Griffith$10K
R-VA-9 · House · 2 PACs
Richard Hudson$10K
R-NC-9 · House · 2 PACs
Kevin Hern$10K
R-OK-1 · House · 2 PACs
John Joyce$10K
R-PA-13 · House · 2 PACs
Kevin Mullin$10K
D-CA-15 · House · 2 PACs
Sarah McBride$10K
D-DE · House · 1 PAC
Scott H. Peters$9,500
D-CA-50 · House · 2 PACs

$449.5K of the $453K its PACs gave to federal candidates went to 125 members of Congress.

Members whose campaigns received from its PACs, 2024 cycle

Lisa Blunt Rochester$10K
D-DE · Senate · 1 PAC
Brett Guthrie$10K
R-KY-2 · House · 1 PAC
John Joyce$10K
R-PA-13 · House · 2 PACs
Katherine M. Clark$9,000
D-MA-5 · House · 2 PACs
Mariannette Miller-Meeks$9,000
R-IA-1 · House · 2 PACs

Direct and in-kind contributions the members' campaigns received (FEC), net of refunds. Party and seat are the member's current or latest.

Bills named in its lobbying reports

H.R. 946 · ORPHAN Cures Act20 reports
119th Congress · Introduced · 2025–2026
H.R. 5376 · Inflation Reduction Act of 202214 reports
117th Congress · Became law · 2023–2025
H.R. 5539 · ORPHAN Cures Act13 reports
118th Congress · Introduced · 2023–2025
S. 3131 · ORPHAN Cures Act11 reports
118th Congress · Introduced · 2023–2025
H.R. 830 · HELP Copays Act8 reports
118th Congress · Introduced · 2023–2024

Amounts, members and bills are as recorded, shown side by side. They say nothing about why a contribution was made, how a member voted or what a report sought. A bill number written in a report is read as the measure of the Congress its context points to (a law's number, the Congress written next to it, the title), else of the Congress then sitting.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 9, 2026, loaded Oct 9, 2026.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 9, 2026, loaded Oct 9, 2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.